Calumet (NASDAQ:CLMT) Director Daniel Sajkowski Sells 3,310 Shares

Calumet, Inc. (NASDAQ:CLMT) Director Daniel Sajkowski sold 3,310 shares of the business’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $34.46, for a total value of $114,062.60. Following the transaction, the director owned 81,958 shares in the company, valued at $2,824,272.68. The trade was a 3.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link.

Calumet Price Performance

Calumet stock opened at $35.06 on Friday. The stock’s 50 day moving average price is $27.92 and its 200 day moving average price is $22.30. Calumet, Inc. has a 1-year low of $7.68 and a 1-year high of $36.94. The company has a market cap of $3.04 billion, a PE ratio of -89.90 and a beta of 0.86.

Calumet (NASDAQ:CLMT) last released its quarterly earnings data on Friday, February 27th. The oil and gas company reported ($0.43) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.67) by $0.24. The business had revenue of $1.04 billion during the quarter, compared to analysts’ expectations of $1.04 billion. During the same quarter in the previous year, the company posted ($0.47) EPS. The company’s revenue was up 9.4% compared to the same quarter last year. On average, equities research analysts anticipate that Calumet, Inc. will post -3.02 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

CLMT has been the topic of a number of research analyst reports. HC Wainwright boosted their price objective on shares of Calumet from $33.00 to $60.00 and gave the stock a “buy” rating in a report on Monday. The Goldman Sachs Group lifted their price target on shares of Calumet from $24.00 to $34.00 and gave the company a “buy” rating in a research report on Thursday, March 12th. Wall Street Zen lowered Calumet from a “buy” rating to a “hold” rating in a research note on Sunday, December 14th. TD Cowen upped their price target on Calumet from $19.00 to $25.00 and gave the stock a “hold” rating in a report on Thursday, March 5th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Calumet in a research note on Monday, December 29th. Four investment analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Calumet currently has an average rating of “Hold” and a consensus price target of $30.17.

Institutional Trading of Calumet

Institutional investors and hedge funds have recently modified their holdings of the business. Islay Capital Management LLC purchased a new stake in Calumet in the 4th quarter valued at approximately $25,000. Aster Capital Management DIFC Ltd boosted its stake in shares of Calumet by 294.7% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after acquiring an additional 1,229 shares during the last quarter. Global Retirement Partners LLC acquired a new stake in shares of Calumet during the fourth quarter valued at $34,000. Covestor Ltd raised its stake in Calumet by 29.1% in the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock valued at $43,000 after purchasing an additional 492 shares during the last quarter. Finally, State of Alaska Department of Revenue acquired a new stake in shares of Calumet during the 3rd quarter worth about $56,000. Hedge funds and other institutional investors own 34.41% of the company’s stock.

Key Headlines Impacting Calumet

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: HC Wainwright raised multiple 2026–2027 EPS estimates and reiterated a “Buy” rating with a $60 price target, shifting FY2027 from a loss forecast to a positive $1.07 EPS — a meaningful expectation upgrade that supports upside in the stock. Article Title
• Positive Sentiment: Brokerage and media coverage highlights (e.g., Zacks) flagged the recent surge and the upward trend in earnings revisions, which can attract momentum buying and higher intraday volume. Article Title
• Neutral Sentiment: Director Daniel J. Sajkowski disclosed a sale of 3,310 shares at ~$34.46 on April 1; the sale is modest relative to his remaining ~81,958 shares but may draw short-term attention from traders tracking insider activity. SEC Form 4
• Negative Sentiment: Operational headwind: Calumet disclosed unplanned maintenance at its Shreveport plant after detecting organic chlorides in feedstock tanks, which could reduce near-term throughput and raise maintenance costs or downtime risk until resolved. PR Newswire

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.